Searchable abstracts of presentations at key conferences in endocrinology

ea0063gp43 | Metabolic Syndrome and Hypoglycaemia | ECE2019

The elevated chemerin plasma concentrations in men diagnosed with metabolic syndrome are correlated with markers of low-grade state inflammation but not with SHBG serum levels and accompanying hypoandrogenemia.

Herman Waldemar , Jarecki Piotr , Kołodziejczak Barbara , Wojcicka Marlena , Losy Jacek , Łęcka Katarzyna

Background: Chemerin (CHEM) is a newly-discovered adipokine involved in the immune, metabolic and reproductive processes. Low-grade state inflammation (LGSI) is a key element in the pathogenesis of metabolic syndrome (MS).Objectives: The aim of the study was to assess the effect of age on MS prevalence, androgenic status as well as on selected inflammatory indices and CHEM plasma concentrations. Additionally we investigated correlations between CHEM and ...

ea0063p666 | Interdisciplinary Endocrinology 1 | ECE2019

Pan-cancer analysis of thyroid hormone signaling pathway reveals new possible targets for combinations therapy

Hanusek Karolina , Popławski Piotr , Piekiełko-Witkowska Agnieszka

Introduction: Published studies suggest links between altered actions of thyroid hormones (TH) and cancer development and progression. It is not clear, however, whether these links are specific to cancer types or whether TH can globally affect cancerogenesis. Here, we performed PanCancer analysis of TH signaling pathway.Material/methods: 79 genes linked with TH signaling pathway, including genes encoding proteins involved in TH synthesis, transport, rece...

ea0041ep1046 | Thyroid (non-cancer) | ECE2016

Exophthalmos as the first manifestation of mantle cell lymphoma of the patient with Hashimoto thyroiditis

Marczewski Krzysztof , Boniek-Poprawa Dorota , Tomaszewski Piotr , Kawałko Agnieszka , Maciejewski Marek

Introduction: The diagnosis of thyroid orbitopathy is based on clinical symptoms and typical changes in laboratory tests confirming thyroid disease. In approximately 5% it is Hashimoto’s thyroiditis. Typical treatment is primarily steroids administered intravenously. But one disease does not exempts the other, and the drugs can not read. Therefore, we would like to present the history of our patient.Case report: 55 year-old man was admitted to the E...

ea0037ep931 | Thyroid (non-cancer) | ECE2015

The efficacy of radioiodine therapy in patients with non-toxic nodular goitre with large cold nodule

Abdelrazek Saeid , Szumowski Piotr , Siewko Katrzyna , Mysliwiec Janusz , Szelachowska Malgorzata , Garkowski Marcin

Most of the patients with the benign cold nodule refuse surgical operation. Radioiodine therapy (RIT) is the choice for these patients. The aim of our study was to evaluate the efficacy of radioiodine therapy to reduce thyroid volume in patients with cold nodule by the use of two doses of radioiodine.Methods: We treated 40 patients with non-toxic nodular goitre with large cold nodule, aged 18 and 48 years; initial 24 h radioiodine uptake (RAIU) was range...

ea0035p25 | Adrenal cortex | ECE2014

Subclinical hypercortisolemia: who should be operated?

Papierska Lucyna , Cwikla Jaroslaw , Rabijewski Michal , Glinicki Piotr , Otto Maciej , Kasperlik-Zaluska Anna

Objective: According to some authors a higher incidence of subclinical hypercortisolaemia is found among patients with bilateral adrenal tumors with benign phenotype than with unilateral ones. The question is whether all patients with bilateral adrenal tumors and subclinical hypercortisolemia should undergo surgery and, if yes, which of the tumors should be removed first.Patients and methods: The investigated group consisted of 25 patients with benign bi...

ea0035p97 | Bone and Osteoporosis | ECE2014

Assessment of OPG/RANK/RANKL gene expression levels in peripheral blood mononuclear cells after treatment with hormonal replacement therapy and tibolone in patients after menopause with osteopenia or postmenopausal osteoporosis

Stuss Michal , Ceglowska Agnieszka , Rieske Piotr , Stepien-Klos Wioletta , Liberski Pawel , Sewerynek Ewa

The aim of the reported study was to assess gene expression levels of the OPG/RANK/RANKL system in peripheral blood mononuclear cells (PBMC) after tibolone and hormonal replacement therapy (HRT) administered to patients with oestrogen deficiency symptoms and osteopenia or postmenopausal osteoporosis.Material and methods: 74 women after menopause, aged 45–71 years, were enrolled into the study and randomly assigned to different medical therapies: HRT...

ea0035p98 | Bone and Osteoporosis | ECE2014

Assessment of OPG and RANKL serum levels after treatment with hormonal replacement therapy and tibolone in patients after menopause with osteopenia or postmenopausal osteoporosis

Stuss Michal , Ceglowska Agnieszka , Rieske Piotr , Stepien-Klos Wioletta , Liberski Pawel , Sewerynek Ewa

The aim of this study was to evaluate quantitative changes in OPG and RANKL proteins after tibolone and hormonal replacement therapy (HRT) administered to patients with oestrogen deficiency symptoms and osteopenia or postmenopausal osteoporosis.Material and methods: A total of 74 women after menopause, aged 45–71 years, patients of the Outpatient Clinic of Osteoporosis of the Military Teaching Hospital in Lodz, were enrolled into the study. The pati...

ea0035p224 | Clinical case reports Pituitary/Adrenal | ECE2014

Cushing's disease in patient with primary empty sella

Kurowska Maria , Malicka Joanna , Zielinski Grzegorz , Tarach Jerzy S , Maksymowicz Maria , Denew Piotr

Introduction: The empty sella syndrome (ESS) is defined as the penetration of the subarachnoid space into intrasellar region. In ESS pituitary hormonal function is usually normal, but several, mostly subtle, hormonal abnormalities have been also reported. The coexistence of Cushing’s disease and primary empty sella is very rare.Objective: The presentation of an exceptional case of a patient with Cushing’s disease associated with primary empty s...

ea0035p225 | Clinical case reports Pituitary/Adrenal | ECE2014

Temozolomide-induced marked regression of invasive Crooke's cells corticotropinoma in patient with Cushing's disease

Kurowska Maria , Malicka Joanna , Zielinski Grzegorz , Tarach Jerzy S , Maksymowicz Maria , Denew Piotr

Introduction: Crooke’s cells are normal corticotrophs with cytoplasmic accumulation of cytokeratin filaments in response to glucocorticoids excess. Crooke’s cell corticotropinomas are the unique cause of Cushing’s disease. Nearly all of them are invasive macroadenomas, generally aggressive, refractory to conventional therapy, with high recurrence rate.Aim of the study was to present a case study of a patient with Cushing’s disease cau...

ea0035p226 | Clinical case reports Pituitary/Adrenal | ECE2014

Treatment of aggressive corticotropinoma with temozolomide and bevacizumab in patient with Nelson's syndrome

Malicka Joanna , Kurowska Maria , Zielinski Grzegorz , Tarach Jerzy S , Maksymowicz Maria , Denew Piotr

Introduction: Aggressive corticotropinomas are more invasive than other pituitary tumors. Recent reports have documented the efficacy of temozolomide alone or in combination with an anti-angiogenic agent –bevacizumab in invasive pituitary adenomas treatment.Objective: Presentation a case of 56-year-old woman initially diagnosed as Cushing’s disease and the analysis of treatment procedures with special concentration on temozolomide and bevacizum...